Company Analysis
IndustriesMedicinal Chemicals & Botanical Products

Medicinal Chemicals & Botanical Products

Open in the Screener
Companies
20
Median grade
4.96
Highest
NAGE 6.82
Lowest
CGC 2.72

A grade ranks a company against its own industry, from its filings. It is not a view on the share price. 20 of 5,495 companies on file are in this industry.

Company, by gradeGrade◀ Past● Present▶ FutureArcFiled
1NAGENiagen Bioscience, Inc.6.825.87.07.7Rising9 of 9
2USNAUSANA Health Sciences Inc6.766.37.36.5Rising9 of 9
3CRONCronos Group Inc.6.446.16.86.3Rising9 of 9
4ACBAurora Cannabis Inc.6.297.15.86.1Falling7 of 9
5RGCRegencell Bioscience Holdings Limited6.256.35.57.2Rising2 of 9
6SNDLSNDL Inc.5.886.36.54.6Falling8 of 9
7FTLFFitLife Brands, Inc.5.835.35.86.5Rising9 of 9
8TRLVTrulieve Cannabis Corp.5.465.26.05.0Falling9 of 9
9DFTXDefinium Therapeutics, Inc.5.324.45.26.5Rising3 of 9
10GLASGlass House Brands Inc.4.966.14.93.9Falling8 of 9
11TLRYTilray Brands, Inc.4.953.95.94.7Rising8 of 9
12BTMDBiote Corp.4.774.64.25.6Rising9 of 9
13IMCCIM Cannabis Corp.4.756.44.33.7Falling7 of 9
14NAIINatural Alternatives International, Inc.4.434.24.84.2Level8 of 9
15MTEXMannatech, Incorporated4.323.34.74.8Rising8 of 9
16AKANAkanda Corp.3.834.12.94.7Rising7 of 9
17SNYRSynergy CHC Corp.3.824.73.63.3Falling8 of 9
18MDWDMediWound Ltd.3.775.12.73.9Falling7 of 9
19BONBon Natural Life Limited3.683.93.43.8Falling8 of 9
20CGCCanopy Growth Corporation2.721.42.54.4Rising8 of 9
Next deadlinesfrom the SEC's rules
  • Nov 14FTLF10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14NAII10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Jan 9TLRY10-Q due under the SEC's rules, the quarterly report for the period ended 2026-11-30
  • Jan 28BON20-F due under the SEC's rules, the annual report for the period ended 2026-09-30
  • Feb 9CGC10-Q due under the SEC's rules, the quarterly report for the period ended 2026-12-31
  • Mar 1NAGE10-K due under the SEC's rules, the annual report for the period ended 2026-12-31
  • Mar 1TRLV10-K due under the SEC's rules, the annual report for the period ended 2026-12-31

A deadline is the rule's date for the filer's category, never a prediction.

SI Assistanton Medicinal Chemicals & Botanical Products · research, not advice